Literature DB >> 2061619

Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.

T Hirano1.   

Abstract

Interleukin 6 (IL-6) is a multifunctional cytokine regulating immune response acute phase reaction and hematopoiesis. IL-6 plays a critical role in B cell differentiation to plasma cells and is a potent growth factor for plasmacytoma and myeloma. Abnormal production of IL-6 has been suggested to be involved in polyclonal plasma cell abnormalities and plasma cell neoplasias. The deregulated expression of the IL-6 gene in transgenic mice resulted in the generation of malignant plasmacytoma. Based on these findings, it could be considered that continuous IL-6 gene expression plays an essential role in a multistep oncogenesis of plasma cell neoplasias. The role of IL-6 and its receptor in the generation of plasma cell neoplasias and the mechanisms of the IL-6 gene expression and IL-6 receptor-mediated signal transduction are described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2061619     DOI: 10.1002/stem.5530090303

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  30 in total

1.  Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

Authors:  Alex Reza Gholiha; Peter Hollander; Ingrid Glimelius; Gustaf Hedstrom; Daniel Molin; Henrik Hjalgrim; Karin E Smedby; Jamileh Hashemi; Rose-Marie Amini; Gunilla Enblad
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases.

Authors:  Burkhard Möller; Peter M Villiger
Journal:  Springer Semin Immunopathol       Date:  2006-05-09

Review 3.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms.

Authors:  D P Ramji; A Vitelli; F Tronche; R Cortese; G Ciliberto
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

5.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

6.  Interleukin-6 stimulates cell proliferation of rat pituitary clonal cell lines in vitro.

Authors:  T Sawada; K Koike; Y Kanda; H Ikegami; H Jikihara; T Maeda; Y Osako; K Hirota; A Miyake
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

7.  Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.

Authors:  J C Anthes; Z Zhan; H Gilchrest; R W Egan; M I Siegel; M M Billah
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

8.  Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure.

Authors:  R Savino; A Lahm; M Giorgio; A Cabibbo; A Tramontano; G Ciliberto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.

Authors:  Brenda M Birmann; Marian L Neuhouser; Bernard Rosner; Demetrius Albanes; Julie E Buring; Graham G Giles; Qing Lan; I-Min Lee; Mark P Purdue; Nathaniel Rothman; Gianluca Severi; Jian-Min Yuan; Kenneth C Anderson; Michael Pollak; Nader Rifai; Patricia Hartge; Ola Landgren; Lawrence Lessin; Jarmo Virtamo; Robert B Wallace; JoAnn E Manson; Graham A Colditz
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

Review 10.  Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Authors:  Brenda M Birmann; Mollie E Barnard; Kimberly A Bertrand; Ying Bao; Marta Crous-Bou; Brian M Wolpin; Immaculata De Vivo; Shelley S Tworoger
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.